A popular thyroid medicine has been recalled over concerns about its potency. Vitruvias Therapeutics Inc. has recalled one ...

Vitruvias Therapeutics Inc. announced a voluntary recall of one lot (Lot No. 504950) of Thyroid Tablets, USP 30 mg, which was ...

A thyroid medication recall affects 30-milligram tablets due to potential superpotency concerns. Superpotency can cause ...

The Food and Drug Administration announced a recall for one lot of Vitruvias Therapeutics Inc.'s thyroid tablets as they are ...

Nearly 2000 bottles of the prescription medication are being pulled from circulation after testing revealed excess potency levels ...

Less than a month after initiating a drug recall after cardboard was fou | Baxter has initiated a recall of two products ...

The superpotnent medication can cause major heath problems such as muscle weakness, hypertension, chest pain, rapid heart ...

Vitruvias Therapeutics has “ceased operations” after voluntarily recalling a batch recall of generic thyroid tablets due to ...

A nationwide recall was issued for this common thyroid medication. See the recalled products.

A widely used thyroid medication is being recalled nationwide after testing found the tablets didn’t contain enough of their active ingredient. The recall was classified by the U.S. Food and Drug ...

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg because testing found the medication may be ...

Vitruvias Therapeutics has announced a voluntary recall of its thyroid tablets after tests indicated the potential for ...